Empowering outcomes · Driving collaboration · Instilling hope

Built by Advanced Therapy Manufacturers for Advanced Therapy Manufacturers

Get in touch Learn more
Great benefits

We empower life science innovators - from academic labs and blood centres to global CDMOs - to unlock deeper insights and operational excellence. By integrating siloed data into a unified digital ecosystem, autoloMATE® streamlines the journey from initial discovery and clinical trials through to large-scale commercialization.

Learn about the benefits
What we do

Using smart technology, we enable ATMP manufacturers to bring advanced therapy medicines to more patients, making this highly-specialised area of medicine deliverable, available and affordable.

Learn about us
Our opportunities

Creative thinkers and problem solvers, tech enthusiasts or industry savvy – there are limitless opportunities for your talents to make a difference.

Learn about working with us

We empower Advanced Therapy Manufacturers to gain new insights and efficiencies within their workflows

” We have an extremely productive partnership with Autolomous that builds on Autolomous’ efforts to have a thorough understanding of our institution’s needs, working closely with a knowledgeable and talented technical team. “

Steven Feldman
Site Head & Scientific Director
LCGM, Stanford GMP Facility

” We have an extremely productive partnership with Autolomous that builds on Autolomous’ efforts to have a thorough understanding of our institution’s needs, working closely with a knowledgeable and talented technical team .”

Steven Feldman
Site Head & Scientific Director
LCGM, Stanford GMP Facility

Partnerships

We develop innovative IT solutions to provide CGT manufacturers with ways to scale their operations. By leveraging integrations with advanced therapy suppliers, we deliver a seamless end-to-end solution.

Latest news

Stay up to date with Autolomous to gain regular insights into our journey. Visit our news page to explore company updates, media coverage and our latest thinking on industry developments.

See more news
Citeline – Scrip Asks – What Does 2026 Hold For Biopharma? Part 5: AI And Operational Excellence

We are pleased to report that our CEO, Alexander Seyf, featured in the ...

 3 weeks Insight, Press
Cell & Gene Therapy Review – 2026 cell and gene therapy predictions

As we head into 2026, the Cell & Gene Therapy (CGT) sector is shift...

 4 weeks Insight, Press
See more news

Request an info pack

To delve further into what we do at Autolomous, contact us to request an info pack or to get more details.

Contact us